Newly diagnosed AML: quizartinib improves OS

Author:

Publisher website

30 May 2023

journal article
editorial
Published by Springer Nature in Nature Reviews Clinical Oncology

Vol. 20 (8) , 504
DOI:10.1038/s41571-023-00787-6
PMID:37253972

Abstract

No abstract available

This publication has 1 reference indexed in Scilit:

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, 2023